InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-10.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Lonial Sagar, Director. Director active across 1 company, notably TG Therapeutics, INC.. Aggregated, 8 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.1m. History available since 18 June 2021. The latest transaction was disclosed on 11 November 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
5,000 shares@ US$30.4412.9% of flowCommon StockSEC:0001437749-24-034597:0
9,585 shares@ US$16.3913.2% of flowCommon StockSEC:0001437749-24-020851:0
5,000 shares@ US$15.9356.6% of flowCommon StockSEC:0001437749-24-008124:0
20,000 shares0Common StockSEC:0001104659-23-105403:0
34,854 shares@ US$23.3767.3% of flowCOMMON STOCKSEC:0001104659-23-074784:0
43,732 shares0Common StockSEC:0001104659-22-082023:0
20,000 shares0COMMON STOCKSEC:0001104659-21-084260:0
20,000 shares0COMMON STOCKSEC:0001104659-21-084260
8 of 8 declarations
About Lonial Sagar
Sagar Lonial is a Director of TG Therapeutics, Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. His experience and skills in corporate governance are essential for guiding TG Therapeutics, Inc. in its growth and innovation objectives.
